Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Rosas, Erick Alexanderson (57205709570)"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial
    (2023)
    Karthikeyan, Ganesan (57188672173)
    ;
    Peix, Amalia (55899478200)
    ;
    Devasenapathy, Niveditha (23033698100)
    ;
    Jimenez-Heffernan, Amelia (55897520300)
    ;
    Haque, Saif-ul (57218168830)
    ;
    Rodella, Carlo (31067520000)
    ;
    Giubbini, Raffaele (7004319496)
    ;
    Rosas, Erick Alexanderson (57205709570)
    ;
    Ozkan, Elgin (7007024961)
    ;
    Keng, Yung Jih Felix (57942745400)
    ;
    Vitola, João (6602072314)
    ;
    Sobic-Saranovic, Dragana (57202567582)
    ;
    Soni, Manoj (57942104600)
    ;
    López, Leonardo (57941442200)
    ;
    Cabrera, Lázaro O. (14061659500)
    ;
    Camacho-Freire, Santiago (55515266200)
    ;
    Manovel-Sanchez, Ana (14520375700)
    ;
    Naeem, Hesham (57224600165)
    ;
    Fatima, Shazia (8331748200)
    ;
    Rinaldi, Roberto (57217700985)
    ;
    Carvajal-Juarez, Isabel (57203129644)
    ;
    Esenboga, Kerim (55965196800)
    ;
    Dondi, Maurizio (56789705600)
    ;
    Paez, Diana (54785022800)
    Background: In patients with multi-vessel disease presenting with ST elevation myocardial infarction (STEMI), the efficacy and safety of ischemia-guided, vs routine non-culprit vessel angioplasty has not been adequately studied. Methods: We conducted an international, randomized, non-inferiority trial comparing ischemia-guided non-culprit vessel angioplasty to routine non-culprit vessel angioplasty, following primary PCI for STEMI. The primary outcome was the between-group difference in percent ischemic myocardium at follow-up stress MPI. All MPI images were processed and analyzed at a central core lab, blinded to treatment allocation. Results: In all, 109 patients were enrolled from nine countries. In the ischemia-guided arm, 25/48 (47%) patients underwent non-culprit vessel PCI following stress MPI. In the routine non-culprit PCI arm, 43/56 (77%) patients underwent angioplasty (86% within 6 weeks of randomization). The median percentage of ischemic myocardium on follow-up imaging (mean 16.5 months) was low, and identical (2.9%) in both arms (difference 0.13%, 95%CI − 1.3%–1.6%, P <.0001; non-inferiority margin 5%). Conclusion: A strategy of ischemia-guided non-culprit PCI resulted in low ischemia burden, and was non-inferior to a strategy of routine non-culprit vessel PCI in reducing ischemia burden. Selective non-culprit PCI following STEMI offers the potential for cost-savings, and may be particularly relevant to low-resource settings. (CTRI/2018/08/015384). © 2022, The Author(s).

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback